M&A news

Gilead Sciences Acquires ACLX Limited in $

ACLX Limited acquired by Gilead Sciences

Acquisition$7,800,000,000Entertainment ProvidersNZ

Get the full ACLX Limited company profile

Access contacts, investors, buying signals & more

Open in Dashboard
ACLX Limited logo
Acquired

ACLX Limited

New ZealandEntertainment Providers

Deal value

$7,800,000,000

March 18, 2026

Gilead Sciences logo
Acquirer

Gilead Sciences

Biotechnology Research

Gilead Sciences has acquired ACLX Limited for $7.8 billion, marking a significant corporate transaction. This acquisition sees the biopharmaceutical company integrate an entity known for its event production and services.

ACLX Limited, with over two decades of experience, has established itself as Waikato's most comprehensive supplier of production equipment and services. Originating from humble beginnings, the company now caters to a diverse range of events, including weddings, parties, corporate functions, shows, theatre productions, and festivals. ACLX prides itself on providing state-of-the-art lighting, audio, and AV equipment, ensuring each event is equipped with the best technology available. Its team of experts and dedicated technicians work tirelessly to meet client needs, leveraging years of experience for equipment installation, lighting design, and event

No buying signals identified yet.

Unlock GTM signals

Discover ACLX Limited's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at ACLX Limited.

Unlock decision-makers